Valuation: CStone Pharmaceuticals

Market Cap 733.1Cr 109.31Cr 95Cr 90Cr 82Cr 152.95Cr 10TCr 153.7Cr 1.07TCr 415.01Cr 5.32TCr 410.64Cr 401.5Cr 17TCr P/E 2026 *
-15.9x
P/E 2027 * 7.71x
Enterprise Value 635.33Cr 95Cr 83Cr 78Cr 71Cr 132.55Cr 9.07TCr 133.2Cr 930.14Cr 359.66Cr 4.61TCr 355.87Cr 347.95Cr 15TCr EV / Sales 2026 *
15x
EV / Sales 2027 * 1.92x
Free-Float
79.9%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day+33.09%
Current month+30.13%
1 month+30.13%
3 months+53.22%
6 months+5.77%
Current year+2.00%
1 month 0.68
Extreme 0.6844
0.91
Current year 0.59
Extreme 0.5945
1.01
1 year 0.59
Extreme 0.5945
1.01
3 years 0.11
Extreme 0.1139
1.01
5 years 0.11
Extreme 0.1139
1.58
10 years 0
Extreme 0.0001
2.6
Manager TitleAgeSince
Chief Executive Officer 62 25/08/2022
Director of Finance/CFO - 18/01/2023
Chief Operating Officer 46 01/08/2016
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 25/08/2022
Director/Board Member 63 09/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
+33.09%0.00% - - 105.56Cr
+1.07%-1.36%+33.64%-5.10% 7.73TCr
+1.81%+3.71%-12.06%-33.66% 5.96TCr
+8.70%+14.88%+527.80%+50.71% 5.81TCr
-0.92%-3.86%-12.36%+24.21% 4.76TCr
+1.21%+3.42%+2.76%+151.63% 4.53TCr
+1.11%+1.12%+50.37%-14.00% 3.19TCr
+1.42%+2.48%+48.98%+112.29% 2.53TCr
+2.18%-2.09%-0.10%+145.28% 2.09TCr
+1.46%+1.60%+62.58%+102.27% 1.56TCr
Average +5.10%+0.11%+77.96%+59.29% 4.24TCr
Weighted average by Cap. +2.30%+0.39%+94.11%+40.87%

Financials

2026 *2027 *
Net sales 42Cr 6.31Cr 5.5Cr 5.2Cr 4.73Cr 8.83Cr 604.27Cr 8.87Cr 62Cr 24Cr 307.09Cr 24Cr 23Cr 983.08Cr 172.22Cr 26Cr 22Cr 21Cr 19Cr 36Cr 2.46TCr 36Cr 252.14Cr 97Cr 1.25TCr 96Cr 94Cr 4TCr
Net income -38Cr -5.72Cr -4.98Cr -4.71Cr -4.28Cr -8Cr -547.71Cr -8.04Cr -56Cr -22Cr -278.35Cr -21Cr -21Cr -891.06Cr 68Cr 10Cr 8.84Cr 8.36Cr 7.6Cr 14Cr 971.7Cr 14Cr 100Cr 39Cr 493.83Cr 38Cr 37Cr 1.58TCr
Net Debt -98Cr -15Cr -13Cr -12Cr -11Cr -20Cr -1.4TCr -20Cr -143.14Cr -55Cr -709.54Cr -55Cr -54Cr -2.27TCr -402.28Cr -60Cr -52Cr -49Cr -45Cr -84Cr -5.74TCr -84Cr -588.94Cr -227.73Cr -2.92TCr -225.33Cr -220.31Cr -9.35TCr
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
102
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.599CNY
Average target price
12.38CNY
Spread / Average Target
+169.16%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!